Redwood Investment Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,630
Closed -$468K 313
2024
Q4
$468K Buy
+41,630
New +$732K 0.05% 258
2024
Q3
Sell
-27,011
Closed -$552K 319
2024
Q2
$552K Buy
+27,011
New +$690K 0.05% 270
2024
Q1
Sell
-18,906
Closed -$624K 342
2023
Q4
$624K Buy
+18,906
New +$535K 0.06% 272
2022
Q3
Sell
-86,385
Closed -$2.65M 236
2022
Q2
$2.65M Sell
86,385
-1,079
-1% -$31.4K 0.45% 52
2022
Q1
$2.83M Buy
87,464
+5,470
+7% +$143K 0.42% 63
2021
Q4
$2.27M Sell
81,994
-1,414
-2% -$40.6K 0.3% 61
2021
Q3
$2.59M Sell
83,408
-1,900
-2% -$45.6K 0.37% 56
2021
Q2
$1.8M Buy
85,308
+12,948
+18% +$259K 0.29% 65
2021
Q1
$1.46M Sell
72,360
-8,852
-11% -$168K 0.28% 69
2020
Q4
$1.3M Sell
81,212
-8,543
-10% -$113K 0.22% 74
2020
Q3
$1.11M Buy
+89,755
New +$1.06M 0.28% 83

Other funds holding EVH

Redwood Investment Management's EVH Position: Q1 2025 in Review

Redwood Investment Management sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 41,630 shares — an estimated $468K sold.

Redwood Investment Management first reported a position in EVH in Q3 2020 and held it in 11 quarters. The position peaked at $2.83M in Q1 2022. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Redwood Investment Management reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Redwood Investment Management sold 41,630 Evolent Health shares in Q1 2025, an estimated $468K.
  • Redwood Investment Management first reported a position in Evolent Health in Q3 2020 and held it in 11 quarters.
  • Redwood Investment Management's Evolent Health position peaked at $2.83M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Redwood Investment Management's 13F filing for Q1 2025, filed 14 May 2025.